An anti-human ICAM-1 antibody inhibits human rhinovirus infection in the mouse model of human major group rhinovirus infection

S. Traub, A. Carruthers, R. Dunmore, L. Gogsadze, N. W. Bartlett, W. Hao, Q. Zhu, K. Bernard, M. Dymond, A. Leishman, A. Humbles, I. K. Anderson, R. Kolbeck, M. Sleeman, T. Wells, S. L. Johnston (London, Cambridge, Charnwood, United Kingdom; Gaithersburg, United States Of America)

Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Session: Insight into mechanisms of respiratory infections
Session type: Poster Discussion
Number: 3501
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Traub, A. Carruthers, R. Dunmore, L. Gogsadze, N. W. Bartlett, W. Hao, Q. Zhu, K. Bernard, M. Dymond, A. Leishman, A. Humbles, I. K. Anderson, R. Kolbeck, M. Sleeman, T. Wells, S. L. Johnston (London, Cambridge, Charnwood, United Kingdom; Gaithersburg, United States Of America). An anti-human ICAM-1 antibody inhibits human rhinovirus infection in the mouse model of human major group rhinovirus infection. Eur Respir J 2011; 38: Suppl. 55, 3501

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation
Source: Eur Respir J 2011; 37: 44-52
Year: 2011



Impact of the presence of serum neutralising antibodies on recruitment into experimental rhinovirus infection studies in asthmatic subjects
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009


Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of human respiratory syncytial virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


The prevalence of specific SARS IgG in different human group
Source: Eur Respir J 2005; 26: Suppl. 49, 597s
Year: 2005

Reduced chemokine responses in human neonatal cells upon infection with RSV.
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017

Rhinovirus infection of human macrophages causes TNF-α production through an NF-κ B dependent mechanism
Source: Eur Respir J 2004; 24: Suppl. 48, 483s
Year: 2004

Effects of respiratory syncytial virus and adenovirus infection in cytokine expression and nuclear factor-κB activation human bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 192s
Year: 2006

Syncytial respiratory virus (SRV) infection of primary human epithelial cells reduces ciliary beat frequency and muc5AC expression
Source: Annual Congress 2009 - Translational models of lung disease
Year: 2009


Responses to rhinovirus infection in human lung slices are reduced by rupintrivir
Source: International Congress 2016 – Immune responses in the lung
Year: 2016

Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells
Source: Eur Respir J 2006; 28: 51-58
Year: 2006



Human rhinovirus 16 infection of human macrophages impairs internalisation via disrupting the actin cytoskeleton
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Human rhinovirus 16 infection of human macrophages impairs their clearance ability by perturbing phagosome maturation
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



HIV protease inhibitors and human endothelial cells
Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens
Year: 2007



Human respiratory syncytial virus infection in vivo and in vitro induces expression of the B cell differentiation factor BAFF
Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences
Year: 2011


LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013

Fas-deficiency is deleterious in a murine model of RSV infection
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009

Modulation of human macrophage IL-15 production by respiratory syncytial virus
Source: Eur Respir J 2005; 26: Suppl. 49, 248s
Year: 2005

RSV infection induces MDC production in respiratory epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 482s
Year: 2004

Rhinovirus infection upregulates SLPI in macrophages
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011


The histological effects of interleukin-10 on mouse lung inflammation after recombinant Sendai virus vector transduction
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007